ONC
Beone MedicinesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ONC Profile
Beone Medicines Ltd.
A Chinese developer of innovative, molecularly targeted and immuno-oncology drugs to treat cancer
Pharmaceutical
10/28/2010
02/03/2016
NASDAQ Stock Exchange
11,000
12-31
Depository Receipts (Ordinary Shares)
No. 30 Science Park Road, Zhong-Guan-Cun Life Science Park, Changping District, Beijing, PRC
Research, develop, produce and commercialize innovative drugs.
Beigene, Ltd.'s main business is research, development, production and commercialization of innovative drugs. The company's main products are Baiyueze, Baizean, Baihuize, Angavir, Belitor, Kailos, Savinco, Kaiser Bai, Pubexi (a biosimilar of Avaserelin), Baituowei (goserelin microspheres for injection), Tafina (dalafenib), Mejining (trametinib), Viquant (pazopanib), Fenito (everolimus), Zancoda (ceritinib). As of the end of the reporting period, the invention patents owned by the company and its holding subsidiaries include 64 invention patents in the United States, 67 invention patents in China, 30 invention patents in Japan, 15 invention patents in Europe and 135 invention patents in other countries or regions.
